at least three other NTDs: foodborne trematodiases, 
rabies, and yaws (endemic treponematoses). 
(2) The United States Agency for International 
Development (USAID) Neglected Tropical Diseases 
Program has made important and substantial con-
tributions to the global fight to control and eliminate 
the seven most common NTDs. Leveraging more 
than $6.7 billion in donated medicines, USAID has 
supported the distribution of more than one billion 
treatments in 25 countries across Africa, Asia, and 
Latin America and the Caribbean. 
(3) United States Government leadership has 
been instrumental in maintaining the global fight 
against NTDs and is a partner in the 2012 London 
Declaration on NTDs, which represents a new, co-
ordinated push to accelerate progress toward elimi-
nating or controlling 10 neglected tropical diseases 
by 2020. 
(4) The USAID NTDs Program is a clear ex-
ample of a successful public-private partnership be-
tween the Government and the private sector and 
should be judiciously expanded. 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that the USAID NTDs Program (as in effect on 
VerDate Sep 11 2014 
07:22 Apr 17, 2015
Jkt 049200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H1797.IH
H1797
SSpencer on DSK4SPTVN1PROD with BILLS
the date of the enactment of this Act) should be modified 
as follows: 
(1) Provide rapid impact package treatments to 
as many individuals suffering from NTDs or at risk 
of acquiring NTDs as logistically feasible. 
(2) Better integrate rapid impact package 
treatments with programs to control and eliminate 
HIV/AIDS and malaria, as well as improved access 
to water, sanitation, and hygiene (WASH) pro-
grams, including— 
(A) by coordinating HIV/AIDS programs 
with the control of female genital schistoso-
miasis, now revealed as one of Africa’s most im-
portant co-factors in its AIDS epidemic; and 
(B) by coordinating malaria programs with 
programs to control schistosomiasis and hook 
worm—together these diseases produce pro-
found and severe anemia. 
(3) Establish school-based NTD programs to 
provide an opportunity to reach large numbers of 
school-age children who require treatments for 
NTDs, including rapid impact package treatments 
as feasible and at very low cost. 
(4) For other NTDs, such as human African 
trypanosomiasis (sleeping sickness), Chagas disease, 
VerDate Sep 11 2014 
01:54 Apr 18, 2015
Jkt 049200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H1797.IH
H1797
SSpencer on DSK4SPTVN1PROD with BILLS
leishmaniasis, and dengue fever, develop new ap-
proaches to reach the goals relating to the elimi-
nation of NTDs as set forth in the World Health 
Organization (WHO) NTD Roadmap. 
(c) EXPANSION OF PROGRAM.—The Administrator of 
USAID shall expand the USAID NTDs Program (as in 
effect on the date of the enactment of this Act) as follows: 
(1) Carry out monitoring and evaluation to pro-
vide accurate measurements to inform future NTD 
control and elimination strategies. 
(2) Coordinate with USAID development sec-
tors, such as sectors relating to water and sanita-
tion, hygiene, food security and nutrition, and edu-
cation (both primary and preprimary), to establish 
programs that address NTDs and advance the goals 
of the 2012 London Declaration on NTDs. 
(3) Include morbidity management in treatment 
plans for high-burden NTDs, such as lymphatic fila-
riasis (elephantiasis). 
(4) Include NTDs that are recognized as high- 
burden diseases in the Global Burden of Disease 
Study 2010, including foodborne trematodiases, 
human African trypanosomiasis (sleeping sickness), 
Chagas disease, leishmaniasis, and dengue fever and 
related arbovirus infections. 
VerDate Sep 11 2014 
01:54 Apr 18, 2015
Jkt 049200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H1797.IH
H1797
SSpencer on DSK4SPTVN1PROD with BILLS
(5) Include research and development, con-
sistent with other USAID disease prevention pro-
grams, to ensure the tools required for elimination 
of these diseases are available, such as drugs, 
diagnostics, vaccines. 
(d) RESEARCH AND DEVELOPMENT.— 
(1) ESTABLISHMENT.—The Administrator of 
USAID shall establish a research and development 
program within the USAID NTDs Program (as in 
effect on the date of the enactment of this Act). 
(2) PRIORITY.—The research and development 
program shall focus on the prevention and control of 
those diseases with the highest need for new treat-
ments, diagnostics, and vaccines, including soil 
transmitted helminthiases (STH) (round worm, whip 
worm, and hook worm), schistosomiasis, Chagas dis-
ease, human African trypanosomiasis (sleeping sick-
ness), leishmaniasis, Ebola, and dengue fever and 
other arbovirus infections. 
SEC. 102. ACTIONS BY DEPARTMENT OF STATE. 
(a) OFFICE OF THE GLOBAL AIDS COORDINATOR.— 
Section 1(f)(2)(B)(ii) of the State Department Basic Au-
thorities Act of 1956 (22 U.S.C. 2651a(f)(2)(B)(ii)) is 
amended by adding at the end the following: 
VerDate Sep 11 2014 
01:54 Apr 18, 2015
Jkt 049200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6201
E:\BILLS\H1797.IH
H1797
SSpencer on DSK4SPTVN1PROD with BILLS
‘‘(XIV) NEGLECTED
TROPICAL 
DISEASES.— 
‘‘(aa) IN GENERAL.—Ensur-
ing coordination of activities of 
the 
United 
States 
(including 
funding) relating to combatting 
HIV/AIDS with activities of the 
United States (including funding) 
relating to combatting neglected 
tropical diseases to include the 
control and elimination of ne-
glected tropical diseases, particu-
larly in countries and regions 
that are highly endemic for fe-
male genital schistosomiasis. 
‘‘(bb) DEFINITION.—In this 
subclause, the term ‘neglected 
tropical diseases’ has the mean-
ing given the term in section 5 of 
the End Neglected Tropical Dis-
eases Act.’’. 
(b) GLOBAL FUND.— 
(1) IN
GENERAL.—The Secretary of State 
should seek to engage the Global Fund in discus-
sions on whether to expand the authority of the 
VerDate Sep 11 2014 
07:22 Apr 17, 2015
Jkt 049200
PO 00000
Frm 00014
Fmt 6652
Sfmt 6201
E:\BILLS\H1797.IH
H1797
SSpencer on DSK4SPTVN1PROD with BILLS